These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 3156640)
1. Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia. Nurden AT; Didry D; Kieffer N; McEver RP Blood; 1985 Apr; 65(4):1021-4. PubMed ID: 3156640 [TBL] [Abstract][Full Text] [Related]
2. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation. Fournier DJ; Kabral A; Castaldi PA; Berndt MC Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684 [TBL] [Abstract][Full Text] [Related]
3. Diversity of glycoprotein deficiencies in Glanzmann's thrombasthenia. Meyer M; Herrmann FH Thromb Haemost; 1985 Oct; 54(3):626-9. PubMed ID: 2935964 [TBL] [Abstract][Full Text] [Related]
4. Normal synthesis and expression of endothelial IIb/IIIa in Glanzmann's thrombasthenia. Giltay JC; Leeksma OC; Breederveld C; van Mourik JA Blood; 1987 Mar; 69(3):809-12. PubMed ID: 3545321 [TBL] [Abstract][Full Text] [Related]
5. Glycoprotein IIb-IIIa complex in platelets of patients and heterozygotes of Glanzmann's thrombasthenia. Herrmann FH; Meyer M; Gogstad GO; Solum NO Thromb Res; 1983 Dec; 32(6):615-22. PubMed ID: 6229900 [TBL] [Abstract][Full Text] [Related]
6. Quantitation of platelet fibrinogen and thrombospondin in Glanzmann's thrombasthenia by electroimmunoassay. Disdier M; Legrand C; Bouillot C; Dubernard V; Pidard D; Nurden AT Thromb Res; 1989 Mar; 53(6):521-33. PubMed ID: 2499944 [TBL] [Abstract][Full Text] [Related]
7. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane. Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957 [TBL] [Abstract][Full Text] [Related]
8. Inheritance of the human platelet alloantigen, PlA1, in type I Glanzmann's thrombasthenia. Kunicki TJ; Pidard D; Cazenave JP; Nurden AT; Caen JP J Clin Invest; 1981 Mar; 67(3):717-24. PubMed ID: 7193688 [TBL] [Abstract][Full Text] [Related]
9. Characterization of an antibody to the integrin beta 3 subunit (GP IIIa) from a patient with neonatal thrombocytopenia and an inherited deficiency of GP IIb-IIIa complexes in platelets (Glanzmann's thrombasthenia). Jallu V; Pico M; Chevaleyre J; Vézon G; Kunicki TJ; Nurden AT Hum Antibodies Hybridomas; 1992 Apr; 3(2):93-106. PubMed ID: 1633270 [TBL] [Abstract][Full Text] [Related]
10. Two human antibodies reacting with different epitopes on integrin beta 3 of platelets and endothelial cells. Jallu V; Diaz-Ricart M; Ordinas A; Pico M; Vezon G; Nurden AT Eur J Biochem; 1994 Jun; 222(3):743-51. PubMed ID: 7517865 [TBL] [Abstract][Full Text] [Related]
11. Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry. Jennings LK; Ashmun RA; Wang WC; Dockter ME Blood; 1986 Jul; 68(1):173-9. PubMed ID: 3719095 [TBL] [Abstract][Full Text] [Related]
12. Expression of the alloantigen Zwa (or P1A1) on human vascular smooth muscle cells and foreskin fibroblasts: a study on normal individuals and a patient with Glanzmann's thrombasthenia. Giltay JC; Brinkman HJ; von dem Borne AE; van Mourik JA Blood; 1989 Aug; 74(3):965-70. PubMed ID: 2473812 [TBL] [Abstract][Full Text] [Related]
13. A new variant of thrombasthenia with abnormally glycosylated GP IIb/IIIa. Tanoue K; Hasegawa S; Yamaguchi A; Yamamoto N; Yamazaki H Thromb Res; 1987 Aug; 47(3):323-33. PubMed ID: 3629560 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a monoclonal antibody ITI-Pl 1 directed against human platelet membrane glycoprotein IIb using extracts of whole platelets and platelet surface and intracellular membranes. Thorsen LI; Gaudernack G; Hack N; Wilkinson JM; Brosstad F; Solum NO; Crawford N Br J Haematol; 1988 Jan; 68(1):67-74. PubMed ID: 3278733 [TBL] [Abstract][Full Text] [Related]
15. Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome. Hagen I; Nurden A; Bjerrum OJ; Solum NO; Caen J J Clin Invest; 1980 Mar; 65(3):722-31. PubMed ID: 7354135 [TBL] [Abstract][Full Text] [Related]
16. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. Ginsberg MH; Lightsey A; Kunicki TJ; Kaufmann A; Marguerie G; Plow EF J Clin Invest; 1986 Oct; 78(4):1103-11. PubMed ID: 2428841 [TBL] [Abstract][Full Text] [Related]
17. Megakaryocytes from the marrow of a patient with Glanzmann's thrombasthenia lacked GP IIb-IIIa complexes. Hourdillé P; Fialon P; Belloc F; Namur M; Boisseau MR; Nurden AT Thromb Haemost; 1986 Aug; 56(1):66-70. PubMed ID: 3535160 [TBL] [Abstract][Full Text] [Related]
18. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder. Hardisty R; Pidard D; Cox A; Nokes T; Legrand C; Bouillot C; Pannocchia A; Heilmann E; Hourdillé P; Bellucci S Blood; 1992 Aug; 80(3):696-708. PubMed ID: 1638023 [TBL] [Abstract][Full Text] [Related]
19. Antibodies against platelet membrane glycoproteins. II. Influence on ADP- and collagen-induced platelet aggregation, crossed immunoelectrophoresis studies and relevance to Glanzmann's thrombasthenia. Jenkins CS; Ali-Briggs EF; Clemetson KJ Br J Haematol; 1981 Nov; 49(3):439-47. PubMed ID: 6457625 [TBL] [Abstract][Full Text] [Related]
20. Platelet phenotyping in carriers for Glanzmann's thrombasthenia: a simple screening test for assessment of the molecular defect. Morel-Kopp MC; Clemenceau S; Schlegel N; Lecompte T; Aurousseau MH; Kaplan C Transfus Med; 1995 Jun; 5(2):123-9. PubMed ID: 7655575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]